G
Greenleaf develops next-generation crop protectants utilizing bacteriophages for sustainable disease management. These phage-based solutions offer targeted efficacy against specific crop diseases both in the field and during storage. The company provides non-toxic alternatives for agricultural disease control, supporting global food security.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Greenleaf develops next-generation crop protectants utilizing bacteriophages for sustainable disease management. These phage-based solutions offer targeted efficacy against specific crop diseases both in the field and during storage. The company provides non-toxic alternatives for agricultural disease control, supporting global food security.